SKI Market

A+| A| A-|

Indian Indices

Sensex

76,913.50 -582.86
( -0.75%)

Global Indices

Nasdaq

49,530.46 -142.69
(-0.29%)

Dow Jones

7,252.74 22.73
(0.31%)

Hang Seng

59,594.47 309.55
(0.52%)

Nikkei 225

10,375.34 -3.48
(-0.03%)

Forex

USD-INR

94.96 0.17
(0.17%)

EUR-INR

111.11 0.25
(0.23%)

GBP-INR

128.48 0.55
(0.43%)

JPY-INR

0.60 0.01
(1.28%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Silgo Retail Ltd

Industry : Diamond Cutting / Jewellery

BSE Code

ISIN Demat

Book Value()

535117

INE01II01013

45.9368391

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SILGO

34.79

194.3

EPS(TTM)

Face Value()

Div & Yield %

2.27

Back

supha pharmachem ltd

Balaxi Pharmaceuticals consolidated net profit declines 95.42% in the September 2025 quarter

Nov 11,2025

Net profit of Balaxi Pharmaceuticals declined 95.42% to Rs 0.21 crore in the quarter ended September 2025 as against Rs 4.59 crore during the previous quarter ended September 2024. Sales declined 27.40% to Rs 56.18 crore in the quarter ended September 2025 as against Rs 77.38 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	56.18	77.38	-27
OPM %	2.06	13.69	-
PBDT	1.86	6.03	-69
PBT	1.38	5.56	-75
NP	0.21	4.59	-95

76,913.50 -582.86 ( -0.75%)

49,530.46 -142.69 (-0.29%)

7,252.74 22.73 (0.31%)

59,594.47 309.55 (0.52%)

10,375.34 -3.48 (-0.03%)

94.96 0.17 (0.17%)

111.11 0.25 (0.23%)

128.48 0.55 (0.43%)

0.60 0.01 (1.28%)